Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1984-11-13
|
pubmed:language |
pol
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0043-5147
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
420-2
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6385484-Adult,
pubmed-meshheading:6385484-Clinical Trials as Topic,
pubmed-meshheading:6385484-Ergolines,
pubmed-meshheading:6385484-Female,
pubmed-meshheading:6385484-Humans,
pubmed-meshheading:6385484-Male,
pubmed-meshheading:6385484-Middle Aged,
pubmed-meshheading:6385484-Migraine Disorders,
pubmed-meshheading:6385484-Nicergoline
|
pubmed:year |
1984
|
pubmed:articleTitle |
[Use of nicergoline (Sermion) in the treatment of migraine].
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract
|